White Papers
Unlock Faster, More Confident Biosimilar Development
Developing biosimilars requires rigorous analytical characterization to ensure safety, efficacy, and regulatory approval.
Master Measurement Uncertainty in Laboratory Weighing
Every laboratory measurement carries some level of uncertainty—but in regulated environments, uncontrolled variation can compromise compliance, data integrity, and research outcomes.
Unlock Smarter Lifecycle Strategies for Injectable Therapeutics
As the injectable drug market continues to expand - driven by the rise of biologics, biosimilars, and patient-centric therapies-pharmaceutical companies face increasing pressure to differentiate their products, reduce costs, and optimize delivery systems.
Discover Why Douglas Softgels Are the Smarter Choice for Oral Drug Formulation
From improved stability and shelf-life to enhanced patient compliance, softgel technology is redefining oral medicines.
How to optimize your results and overcome specificity challenges in gene expression analysis
Real-time PCR for gene expression analysis is commonly used to quantify gene-specific RNA transcripts expressed by cells or viruses. However, gene expression analysis presents unique challenges, as experimental results often do not follow predictable patterns, and reliable positive controls are not always available.
New modalities, new tools Choosing a flexible digital platform for drug discovery
As pharmaceutical innovation rapidly evolves, the complexity of data generated from RNA therapeutics, gene therapies, antibody-drug conjugates (ADCs), and protein degraders necessitates a new approach to digital infrastructure.
Enhancing the efficiency of CAR T cell therapy manufacturing through automated bioprocessing
This white paper describes the significance of Cellmation Software in automating and integrating the CAR-T cell manufacturing workflow. Modular instruments enhance flexibility and scalability in cell therapy manufacturing. However, automated control of the processes is critical in reducing manual touchpoints and ensures efficiency and safety.
From Protacs to Dacs : How targeted protein degraders are breaking rules and boundaries in drug design
Advancements in healthcare diagnostics, emphasizing the need for innovative technologies to improve disease detection and patient outcomes.
Protect Your Pharma Supply Chain from Global Disruptions
In today’s unpredictable world, pharmaceutical supply chains face growing risks—from geopolitical tensions and regulatory shifts to raw material shortages and natural disasters.
Discover why Electronic Batch Record Management is the smarter alternative to traditional MES
Pharmaceutical manufacturers are under increasing pressure to ensure compliance, minimize errors, and accelerate batch release.
